Frontiers in Pharmacology (Sep 2022)

Using omics approaches to dissect the therapeutic effects of Chinese herbal medicines on gastrointestinal cancers

  • Si-Yi Li,
  • Si-Yi Li,
  • Si-Yi Li,
  • Wei-Jia Wang,
  • Qiu-Yue Li,
  • Qiu-Yue Li,
  • Peng-Hui Yang,
  • Peng-Hui Yang,
  • Xin-Long Li,
  • Xin-Long Li,
  • Yan Yan,
  • Yong Yuan,
  • Yi-Bin Feng,
  • Ming Hong

DOI
https://doi.org/10.3389/fphar.2022.884822
Journal volume & issue
Vol. 13

Abstract

Read online

Chinese herbal medicines offer a rich source of anti-cancer drugs. Differences between the pharmacology of Chinese herbal medicines and modern synthetic chemicals hinder the development of drugs derived from herbal products. To address this challenge, novel omics approaches including transcriptomics, proteomics, genomics, metabolomics, and microbiomics have been applied to dissect the pharmacological benefits of Chinese herbal medicines in cancer treatments. Numerous Chinese herbal medicines have shown potential anti-tumor effects on different gastrointestinal (GI) cancers while eliminating the side effects associated with conventional cancer therapies. The present study aimed to provide an overview of recent research focusing on Chinese herbal medicines in GI cancer treatment, based on omics approaches. This review also illustrates the potential utility of omics approaches in herbal-derived drug discovery. Omics approaches can precisely and efficiently reveal the key molecular targets and intracellular interaction networks of Chinese herbal medicines in GI cancer treatment. This study summarizes the application of different omics-based approaches in investigating the effects and mechanisms of Chinese herbal medicines in GI cancers. Future research directions are also proposed for this area of study.

Keywords